AIG
RYTM icon

American International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

American International Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,318
Closed -$1.14M – 2207
2024
Q1 		$1.14M Buy
26,318
+781
+3% +$34.2K ﹤0.01% 1231
2023
Q4 		$1.17M Sell
25,537
-103
-0.4% -$3.25K ﹤0.01% 1219
2023
Q3 		$588K Buy
25,640
+911
+4% +$20.4K ﹤0.01% 1510
2023
Q2 		$408K Buy
+24,729
New +$446K ﹤0.01% 1776
2022
Q2 		– Sell
-21,871
Closed -$252K – 3242
2022
Q1 		$252K Sell
21,871
-1,540
-7% -$13.5K ﹤0.01% 2107
2021
Q4 		$234K Sell
23,411
-700
-3% -$7.86K ﹤0.01% 2274
2021
Q3 		$315K Sell
24,111
-573
-2% -$8.75K ﹤0.01% 2144
2021
Q2 		$483 Buy
24,684
+2,472
+11% +$51.3K ﹤0.01% 1947
2021
Q1 		$472 Buy
22,212
+2,670
+14% +$77.4K ﹤0.01% 1875
2020
Q4 		$581 Sell
19,542
-559
-3% -$14.2K ﹤0.01% 1670
2020
Q3 		$436K Sell
20,101
-458
-2% -$10.5K ﹤0.01% 1662
2020
Q2 		$458K Buy
20,559
+3,209
+18% +$62.5K ﹤0.01% 1647
2020
Q1 		$264K Sell
17,350
-1,003
-5% -$18K ﹤0.01% 1755
2019
Q4 		$421K Buy
18,353
+3,846
+27% +$85.4K ﹤0.01% 1786
2019
Q3 		$313K Sell
14,507
-101
-0.7% -$2.17K ﹤0.01% 1923
2019
Q2 		$321K Buy
14,608
+4,901
+50% +$124K ﹤0.01% 1958
2019
Q1 		$266K Sell
9,707
-314
-3% -$9.02K ﹤0.01% 2055
2018
Q4 		$269K Sell
10,021
-77
-0.8% -$2.13K ﹤0.01% 2014
2018
Q3 		$295K Buy
10,098
+2,114
+26% +$66.8K ﹤0.01% 2184
2018
Q2 		$250K Buy
7,984
+2,719
+52% +$74.3K ﹤0.01% 2234
2018
Q1 		$105K Sell
5,265
-284
-5% -$7.54K ﹤0.01% 2638
2017
Q4 		$161K Buy
+5,549
New +$147K ﹤0.01% 2450

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's RYTM Position: Q2 2024 in Review

American International Group sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2024, closing a stake of 26,318 shares — an estimated $1.14M sold.

American International Group first reported a position in RYTM in Q4 2017 and held it in 22 quarters. The position peaked at $1.17M in Q4 2023. 165 funds tracked by Wall St. Rank hold RYTM as of Q2 2024.

  • American International Group reported no remaining Rhythm Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 26,318 Rhythm Pharmaceuticals shares in Q2 2024, an estimated $1.14M.
  • American International Group first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 22 quarters.
  • American International Group's Rhythm Pharmaceuticals position peaked at $1.17M in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.